These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34901676)

  • 1. Retraction of "Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis".
    Wu Y; Sreeharsha N; Sharma S; Mishra A; Singh AK; Gubbiyappa SK
    ACS Omega; 2021 Dec; 6(48):33239. PubMed ID: 34901676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis.
    Wu Y; Sreeharsha N; Sharma S; Mishra A; Singh AK; Gubbiyappa SK
    ACS Omega; 2020 Mar; 5(10):5334-5339. PubMed ID: 32201822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone attenuates paraquat-induced lung fibrosis in rats in a PPAR gamma-dependent manner.
    Zhang H; You L; Zhao M
    Eur J Pharmacol; 2019 May; 851():133-143. PubMed ID: 30797787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats.
    Guo YT; Leng XS; Li T; Zhao JM; Lin XH
    World J Gastroenterol; 2004 Dec; 10(23):3419-23. PubMed ID: 15526359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury.
    Rehan VK; Sakurai R; Corral J; Krebs M; Ibe B; Ihida-Stansbury K; Torday JS
    Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L672-80. PubMed ID: 20729387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue.
    Ryu SL; Shim JW; Kim DS; Jung HL; Park MS; Park SH; Lee J; Lee WY; Shim JY
    Korean J Pediatr; 2013 Apr; 56(4):151-8. PubMed ID: 23646053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.
    Nicola T; Ambalavanan N; Zhang W; James ML; Rehan V; Halloran B; Olave N; Bulger A; Oparil S; Chen YF
    Am J Physiol Lung Cell Mol Physiol; 2011 Jul; 301(1):L125-34. PubMed ID: 21531777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
    Nuwormegbe SA; Sohn JH; Kim SW
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats.
    Liu D; Zeng BX; Zhang SH; Wang YL; Zeng L; Geng ZL; Zhang SF
    Crit Care Med; 2005 Oct; 33(10):2309-16. PubMed ID: 16215386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
    Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
    J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, in a mouse allergic asthma model is not associated with the recruitment or generation of Foxp3-expressing CD4
    Maślanka T; Otrocka-Domagała I; Zuśka-Prot M; Gesek M
    Eur J Pharmacol; 2019 Apr; 848():30-38. PubMed ID: 30710547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Fulia F; Cuzzocrea E; Di Rosa M; Caputi AP; Thiemermann C
    Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR-γ agonist rosiglitazone reverses perinatal nicotine exposure-induced asthma in rat offspring.
    Liu J; Sakurai R; Rehan VK
    Am J Physiol Lung Cell Mol Physiol; 2015 Apr; 308(8):L788-96. PubMed ID: 25659902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction of "Cu(II)-Containing Metal-Organic Framework with 1D Hexagonal Channels for Cyanosilylation Reaction and Anticancer Activity on Osteosarcoma Cells".
    Luo J; Ying LF; Zhang F; Zhou Z; Zhang YG
    ACS Omega; 2022 Mar; 7(10):9087. PubMed ID: 35309434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.
    Churi SB; Abdel-Aleem OS; Tumber KK; Scuderi-Porter H; Taylor BK
    J Pain; 2008 Jul; 9(7):639-49. PubMed ID: 18387855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction of "Effect of Reaction Temperature on Shape Evolution of Palladium Nanoparticles and Their Cytotoxicity against A-549 Lung Cancer Cells".
    Abbas G; Kumar N; Kumar D; Pandey G
    ACS Omega; 2023 Jun; 8(25):23226. PubMed ID: 37396278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the impact of PPAR-γ agonist-rosiglitazone on ovarian reserve after hysterectomy? An experimental study.
    Gündoğdu B; Tapisiz ÖL; Dilbaz B; Mülazimoğlu SB; Müftüoğlu KH; Dündar B; Göktolga Ü
    Turk J Med Sci; 2020 Aug; 50(5):1399-1408. PubMed ID: 32394682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of rosiglitazone on paraquat-induced acute lung injury in rats.
    Liu ZN; Zhao M; Zheng Q; Zhao HY; Hou WJ; Bai SL
    Acta Pharmacol Sin; 2013 Oct; 34(10):1317-24. PubMed ID: 23933652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
    Camp HS; Li O; Wise SC; Hong YH; Frankowski CL; Shen X; Vanbogelen R; Leff T
    Diabetes; 2000 Apr; 49(4):539-47. PubMed ID: 10871190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.